DeepMed Research

NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Effect of Vorinostat on Nervous System Hemangioblastomas in Von Hippel-Lindau Disease (Missense Mutation Only)

Phase 1

Completed

Conditions: Von Hippel-Lindau Disease

First Posted Date: 2014-04-09

Last Posted Date: 2018-09-14

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 7

Registration Number: NCT02108002

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database

Not Applicable

Recruiting

Conditions: Epilepsy

Interventions: Device: MRI
Device: MEG

First Posted Date: 2014-04-09

Last Posted Date: 2025-05-07

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 700

Registration Number: NCT02107989

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Depotentiation in People With Focal Hand Dystonia

Terminated

Conditions: Healthy Volunteers
Focal Dystonia

First Posted Date: 2014-04-08

Last Posted Date: 2017-07-02

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 6

Registration Number: NCT02106936

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

fMRI Neurofeedback for Motor Rehabilitation

Terminated

Conditions: fMRI
Stroke

First Posted Date: 2014-03-18

Last Posted Date: 2019-12-17

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 7

Registration Number: NCT02089776

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency

Phase 2

Completed

Conditions: Seizures
Metabolic Disease

Interventions: Drug: Placebo
Drug: SGS-742

First Posted Date: 2013-12-24

Last Posted Date: 2020-02-24

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 19

Registration Number: NCT02019667

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
🇺🇸
Washington State University, Pullman, Washington, United States

Pilot Trial of Botulinum Toxin and Occupational Therapy for Writer's Cramp

Phase 1

Completed

Conditions: Dystonia

Interventions: Drug: BoNT Injections
Procedure: Occupational Therapy

First Posted Date: 2013-12-19

Last Posted Date: 2018-03-20

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 13

Registration Number: NCT02015039

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Functional Brain Imaging in Healthy Volunteers to Study Cognitive Functions

Completed

Conditions: Healthy Volunteers

First Posted Date: 2013-11-01

Last Posted Date: 2019-05-31

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 154

Registration Number: NCT01974427

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Effects of Exercise on Memory in Healthy and Brain-Injured Individuals

Phase 1

Terminated

Conditions: Traumatic Brain Injury

First Posted Date: 2013-09-11

Last Posted Date: 2017-08-30

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 42

Registration Number: NCT01939769

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Natural History and Biomarkers of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Caused by the C9ORF72 Gene Mutation

Completed

Conditions: Amyotrophic Lateral Sclerosis
Frontotemporal Lobar Degeneration

First Posted Date: 2013-08-19

Last Posted Date: 2025-05-06

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 50

Registration Number: NCT01925196

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

A Study of Movement Disorders Using the QMAT At-Home Testing Device

Terminated

Conditions: Parkinson's Disease
Movement Disorders

First Posted Date: 2013-07-23

Last Posted Date: 2018-09-25

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 3

Registration Number: NCT01905839

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy